Accéder au contenu
Merck

Sensitive image-based chromatin binding assays using inducible ERα to rapidly characterize estrogenic chemicals and mixtures.

iScience (2022-10-15)
Adam T Szafran, Maureen G Mancini, Fabio Stossi, Michael A Mancini
RÉSUMÉ

The United States Environmental Protection Agency (EPA) has been pursuing new high throughput in vitro assays to characterize endocrine disrupting chemicals (EDCs) that interact with estrogen receptor signaling. We characterize two new PRL-HeLa cell models expressing either inducible C-terminal (iGFP-ER) or N-terminal (iER-GFP) tagged estrogen receptor-α (ERα) that allows direct visualization of chromatin binding. These models are an order of magnitude more sensitive, detecting 87 - 93% of very weak estrogens tested compared to only 27% by a previous PRL-HeLa variant and compares favorably to the 73% detected by an EPA-developed computational model using in vitro data. Importantly, the chromatin binding assays distinguished agonist- and antagonist-like phenotypes without activity specific assays. Finally, analysis of complex environmentally relevant chemical mixtures demonstrated how chromatin binding data can be used in risk assessment models to predict activity. These new assays should be a useful in vitro tool to screen for estrogenic activity.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-Hydroxytamoxifène, ≥70% Z isomer (remainder primarily E-isomer)
Sigma-Aldrich
Anticorps anti-récepteur à l'œstrogène α, clone 60C, monoclonal de lapin, culture supernatant, clone 60C, from rabbit
Sigma-Aldrich
Bazedoxifene acetate, ≥98% (HPLC)